Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Completed · Phase 4
Conditions studied: Inflammatory Bowel Disease, Uterine Cervical Dysplasia
In brief
The Gardasil vaccine, a vaccine targeted towards the human papillomavirus (HPV), has been shown to prevent the transmission of several strains of HPV in young women. Women with inflammatory bowel disease (IBD) may not respond as well to this vaccine, either due to having IBD or due to immunosuppressants used to control IBD. This study will test how well women with IBD respond to the Gardasil vaccine.
Key facts
- Study ID
- NCT01034358
- Run by
- Mayo Clinic
- People needed
- 15
- Starts
- 2010-02-01
- Expected to finish
- 2011-06-01
- Last updated by the study team
- 2012-10-23
Who can join
Age: 9 and older, up to 26. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women 9-26 years of age
- Have inflammatory bowel disease (ie. Crohns disease or ulcerative colitis)
You may not qualify if…
- Pregnancy
- Taking corticosteroids
- Allergy to yeast aluminum component of the HPV vaccine
- Positive for all HPV types in the Gardasil vaccine-6, 11, 16, 18
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.